Alice B. Gottlieb, MD, PhD, leads a discussion highlighting biosimilar utilization impact on payers and pharmacy benefit managers (PBMs).
This is a video synopsis/summary of a panel discussion involving Ryan Haumschild, PharmD, MS, MBA; Alice B. Gottlieb, MD, PhD; Bincy Abraham, MD, MS; Jamie T. Brogan, APRN; and Vibeke Strand, MD.
Haumschild asks Gottlieb about her experience with payer and pharmacy benefit manager (PBM) coverage of adalimumab (Humira) biosimilars.
Gottlieb says payers and PBMs have almost 100% influence over options. She has no experience yet with adalimumab biosimilars, though they are formulating policies. With infliximab and rituximab biosimilars, use is 100% mandated by the hospital with no branded options. She urged payers and PBMs to ensure lower patient costs and increased access, especially for Medicare patients.
Abraham says payer coverage influences prescribing. If multiple adalimumab biosimilar options are covered, she would choose based on factors like citrate-free formulation, available doses for induction/maintenance, indication-specific data, patient co-pay assistance, and ease of access/prior authorization. It is still early to judge current payer flexibility.
Video synopsis is AI-generated and reviewed by AJMCÒ editorial staff.
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Margin Status Likely Not a Factor in STS Recurrence
May 10th 2024The optimal negative margin required following surgical resection and perioperative radiotherapy for extremity soft tissue sarcoma (STS) remains up for debate, with investigators of a new study using Union for International Cancer Control classification to define resection margin.
Read More
A Focus on Women: AUA Best Posters Highlight Female Athletes, Prenatal Care, and Women in Urology
May 9th 2024Three posters from the American Urological Association (AUA) 2024 Annual Meeting focused on urinary incontinence in female athletes, prenatal care for fetuses with spina bifida in California, and the experiences of women residents at the Brady Urological Institute.
Read More